Article 5 Where the name of a prescription drug is the same as that of a trademark or pharmaceutical manufacturer, it shall not be used to publish advertisements in disguised form in media other than medical and pharmaceutical journals.
It is not allowed to name all kinds of activities with the name of prescription drugs, trademarks registered with the name of prescription drugs and enterprise names.
Article 6 of the Standards for the Examination and Publication of Drug Advertisements shall be based on the instructions approved by the US Food and Drug Administration in the State Council, and shall not be expanded or maliciously concealed, and shall not contain theories and opinions other than the instructions.
Article 7 of the Standards for the Examination and Publication of Drug Advertisements must indicate the general name, suggestion, drug advertisement approval number and drug production approval number in drug advertisements; If the names of various activities are called by the trade names of over-the-counter drugs, only the trade names of drugs can be released.
Drug advertisements must be marked with the names of drug production enterprises or drug trading enterprises, and no separate contents such as "consultation hotline" and "consultation telephone number" may appear.
OTC advertisements must also indicate OTC.
In drug advertisements, product registered trademarks shall not be used instead of drug names for publicity, except for written registered trademarks approved as drug trade names.
Article 12 Drug advertisements shall publicize and guide rational drug use, and shall not directly or indirectly encourage random and excessive purchase and use of drugs, and shall not contain the following contents:
(1) It contains unscientific statements or inappropriate statements, causing the public unnecessary worries and fears about their health status and diseases, or misleading the public to suffer from a certain disease or aggravate their illness without using the drug;
(two) drugs containing free treatment, free gifts, sales with prizes, and taking drugs as gifts or prizes;
(3) Containing "household necessities" or similar contents;
(4) It contains such guarantee contents as "invalid refund" and "insurance of insurance company";
(5) Including comprehensive evaluation contents such as appraisal, ranking, recommendation, designation, selection and award-winning.
Article 13 of the Standards for the Examination and Publication of Drug Advertisements shall not contain the contents evidenced by the names and images of medical scientific research units, academic institutions, medical institutions or experts, doctors and patients.
Drug advertisements shall not use the names of state organs and state functionaries.
Extended data:
Harmful effects:
1. Illegal medical advertisements directly harm the interests of patients and undermine the normal advertising market order and medical work order. All walks of life have strongly reflected this, which has become a hot spot for the masses to report and the focus of NPC deputies and CPPCC members. The harm it causes cannot be underestimated.
2. Because most patients are prone to "rush to the hospital" when they are sick, false medical advertisements have the meaning of "taking advantage of others' danger to hit people". After the patient was misled by false medical advertisements, the disease could not be treated in time and effectively, and the condition worsened, which undoubtedly increased the economic burden of the patient.
3. The high illegal rate of medical advertisements cannot be effectively curbed. The direct consequence is that, on the one hand, it disrupts the normal release, release and management order of the medical advertising market; On the other hand, it disrupts the normal medical and drug market order. Medical institutions spend huge sums of money, do everything possible to "scratch the edge" and even openly advertise illegally to mislead patients.
Baidu Encyclopedia —— Standards for Examination and Publication of Drug Advertisements